Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Setting the record straight: The nosology of tardive syndromes.

Truong DD, Frei K.

Parkinsonism Relat Disord. 2018 Nov 28. pii: S1353-8020(18)30522-4. doi: 10.1016/j.parkreldis.2018.11.025. [Epub ahead of print]

PMID:
30528171
2.

Levodopa-induced dyskinesia: clinical features, incidence, and risk factors.

Tran TN, Vo TNN, Frei K, Truong DD.

J Neural Transm (Vienna). 2018 Aug;125(8):1109-1117. doi: 10.1007/s00702-018-1900-6. Epub 2018 Jul 3. Review.

PMID:
29971495
3.

Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease.

Elmer LW, Juncos JL, Singer C, Truong DD, Criswell SR, Parashos S, Felt L, Johnson R, Patni R.

CNS Drugs. 2018 Apr;32(4):399-400. doi: 10.1007/s40263-018-0510-z.

PMID:
29637528
4.

Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease.

Elmer LW, Juncos JL, Singer C, Truong DD, Criswell SR, Parashos S, Felt L, Johnson R, Patni R.

CNS Drugs. 2018 Apr;32(4):387-398. doi: 10.1007/s40263-018-0498-4. Erratum in: CNS Drugs. 2018 Apr 10;:.

5.

The nosology of tardive syndromes.

Frei K, Truong DD, Fahn S, Jankovic J, Hauser RA.

J Neurol Sci. 2018 Jun 15;389:10-16. doi: 10.1016/j.jns.2018.02.008. Epub 2018 Feb 6.

PMID:
29433810
6.

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial.

Pahwa R, Tanner CM, Hauser RA, Isaacson SH, Nausieda PA, Truong DD, Agarwal P, Hull KL, Lyons KE, Johnson R, Stempien MJ.

JAMA Neurol. 2017 Aug 1;74(8):941-949. doi: 10.1001/jamaneurol.2017.0943.

7.

Design, synthesis and evaluation of indole-2-carboxamides with pan anti-mycobacterial activity.

Franz ND, Belardinelli JM, Kaminski MA, Dunn LC, Calado Nogueira de Moura V, Blaha MA, Truong DD, Li W, Jackson M, North EJ.

Bioorg Med Chem. 2017 Jul 15;25(14):3746-3755. doi: 10.1016/j.bmc.2017.05.015. Epub 2017 May 8.

8.

The sleeping brain in Parkinson's disease: A focus on REM sleep behaviour disorder and related parasomnias for practicing neurologists.

Bhidayasiri R, Sringean J, Rattanachaisit W, Truong DD.

J Neurol Sci. 2017 Mar 15;374:32-37. doi: 10.1016/j.jns.2017.01.018. Epub 2017 Jan 7. Review.

PMID:
28126342
9.

Hallucinations and the spectrum of psychosis in Parkinson's disease.

Frei K, Truong DD.

J Neurol Sci. 2017 Mar 15;374:56-62. doi: 10.1016/j.jns.2017.01.014. Epub 2017 Jan 5. Review.

PMID:
28108020
10.

Editorial and introduction: Behavioral aspects of Parkinson's disease.

Friedman JH, Bhidayasiri R, Truong DD.

J Neurol Sci. 2017 Mar 15;374:1-2. doi: 10.1016/j.jns.2017.01.006. Epub 2017 Jan 4. No abstract available.

PMID:
28087061
12.

High spatial resolution upgrade of the electron cyclotron emission radiometer for the DIII-D tokamak.

Truong DD, Austin ME.

Rev Sci Instrum. 2014 Nov;85(11):11D814. doi: 10.1063/1.4889737.

PMID:
25430227
13.

Treatment of myoclonus-dystonia syndrome with tetrabenazine.

Luciano AY, Jinnah HA, Pfeiffer RF, Truong DD, Nance MA, LeDoux MS.

Parkinsonism Relat Disord. 2014 Dec;20(12):1423-6. doi: 10.1016/j.parkreldis.2014.09.029. Epub 2014 Oct 5.

14.

A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia.

Vemula SR, Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Truong DD, Blitzer A, Rudzińska M, Momčilović D, Jinnah HA, Frei K, Pfeiffer RF, LeDoux MS.

Mol Genet Genomic Med. 2014 May;2(3):261-72. doi: 10.1002/mgg3.67. Epub 2014 Feb 11.

15.

Efficacy and Safety of IncobotulinumtoxinA in Subjects Previously Treated with Botulinum Toxin Versus Toxin-Naïve Subjects with Cervical Dystonia.

Fernandez HH, Pappert EJ, Comella CL, Evidente VG, Truong DD, Verma A, Jankovic J.

Tremor Other Hyperkinet Mov (N Y). 2013 Apr 18;3. pii: tre-03-140-2921-1. doi: 10.7916/D87P8X43. Print 2013.

16.
17.

Role of Gα(olf) in familial and sporadic adult-onset primary dystonia.

Vemula SR, Puschmann A, Xiao J, Zhao Y, Rudzińska M, Frei KP, Truong DD, Wszolek ZK, LeDoux MS.

Hum Mol Genet. 2013 Jun 15;22(12):2510-9. doi: 10.1093/hmg/ddt102. Epub 2013 Feb 27.

18.

Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm.

Truong DD, Gollomp SM, Jankovic J, LeWitt PA, Marx M, Hanschmann A, Fernandez HH; Xeomin US Blepharospasm Study Group.

J Neural Transm (Vienna). 2013 Sep;120(9):1345-53. doi: 10.1007/s00702-013-0998-9. Epub 2013 Feb 23.

19.

Therapeutic strategies for nonmotor symptoms in early Parkinson's disease: the case for a higher priority and stronger evidence.

Bhidayasiri R, Truong DD.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S110-3. doi: 10.1016/S1353-8020(11)70035-9. Review.

PMID:
22166405
20.

Prevalence and diagnostic challenge of dystonia in Thailand: a service-based study in a tertiary university referral centre.

Bhidayasiri R, Kaewwilai L, Wannachai N, Brenden N, Truong DD, Devahastin R.

Parkinsonism Relat Disord. 2011 Nov;17 Suppl 1:S15-9. doi: 10.1016/j.parkreldis.2011.06.014.

PMID:
21999890
21.

Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia.

Comella CL, Jankovic J, Truong DD, Hanschmann A, Grafe S; U.S. XEOMIN Cervical Dystonia Study Group.

J Neurol Sci. 2011 Sep 15;308(1-2):103-9. doi: 10.1016/j.jns.2011.05.041. Epub 2011 Jul 18.

PMID:
21764407
22.

Idebenone induces apoptotic cell death in the human dopaminergic neuroblastoma SHSY-5Y cells.

Tai KK, Pham L, Truong DD.

Neurotox Res. 2011 Nov;20(4):321-8. doi: 10.1007/s12640-011-9245-z. Epub 2011 May 3.

PMID:
21547417
23.

Startle syndromes.

Bhidayasiri R, Truong DD.

Handb Clin Neurol. 2011;100:421-30. doi: 10.1016/B978-0-444-52014-2.00032-X.

PMID:
21496599
24.

Myoclonus.

Caviness JN, Truong DD.

Handb Clin Neurol. 2011;100:399-420. doi: 10.1016/B978-0-444-52014-2.00031-8. Review.

PMID:
21496598
25.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):470. No abstract available.

PMID:
21488298
26.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):470. No abstract available.

PMID:
21488297
27.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):469-70. No abstract available.

PMID:
21488296
28.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):469. No abstract available.

PMID:
21488277
29.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):470. No abstract available.

PMID:
21488252
30.

The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, Frei KP, Blitzer A, Rudzińska M, Pfeiffer RF, Le C, LeDoux MS.

Mov Disord. 2011 Feb 15;26(3):549-52. doi: 10.1002/mds.23551. Epub 2011 Mar 2. Erratum in: Mov Disord. 2012 Mar;27(3):465.

31.

(-)-Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, reduces dichlorodiphenyl-trichloroethane (DDT)-induced cell death in dopaminergic SHSY-5Y cells.

Tai KK, Truong DD.

Neurosci Lett. 2010 Oct 4;482(3):183-7. doi: 10.1016/j.neulet.2010.06.018. Epub 2010 Jun 11.

PMID:
20542083
32.

Memantine exacerbates myoclonic jerks in a rat model of posthypoxic myoclonus.

Tai KK, Truong DD.

Brain Res. 2010 Jul 9;1343:194-8. doi: 10.1016/j.brainres.2010.04.058. Epub 2010 Apr 29.

PMID:
20434435
33.

Novel THAP1 sequence variants in primary dystonia.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, Frei KP, Dev Batish S, Blitzer A, Pfeiffer RF, Gong S, LeDoux MS.

Neurology. 2010 Jan 19;74(3):229-38. doi: 10.1212/WNL.0b013e3181ca00ca.

34.

Current clinical applications of botulinum toxin.

Truong DD, Stenner A, Reichel G.

Curr Pharm Des. 2009;15(31):3671-80. Review.

PMID:
19925419
36.
37.

Recognition and management of Parkinson's disease during the premotor (prodromal) phase.

Truong DD, Wolters EC.

Expert Rev Neurother. 2009 Jun;9(6):847-57. doi: 10.1586/ern.09.50. Review.

PMID:
19496688
38.

High-throughput mutational analysis of TOR1A in primary dystonia.

Xiao J, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, Zhao Y, LeDoux MS.

BMC Med Genet. 2009 Mar 11;10:24. doi: 10.1186/1471-2350-10-24.

39.

Case studies in the advancement of Parkinson's disease.

Frei K, Truong DD, Wolters E.

CNS Spectr. 2008 Dec;13(12 Suppl 18):1-6.

PMID:
19179948
40.

Myoclonus and parkinsonism.

Truong DD, Bhidayasiri R.

Handb Clin Neurol. 2007;84:549-60. doi: 10.1016/S0072-9752(07)84061-9. No abstract available.

PMID:
18808970
41.

Hemifacial spasm producing tremor-like movements of the head.

Frei KP, Truong DD.

J Neurol Sci. 2008 Oct 15;273(1-2):133-4. doi: 10.1016/j.jns.2008.06.011. Epub 2008 Jul 25.

PMID:
18656904
42.

Ketogenic diet prevents cardiac arrest-induced cerebral ischemic neurodegeneration.

Tai KK, Nguyen N, Pham L, Truong DD.

J Neural Transm (Vienna). 2008 Jul;115(7):1011-7. doi: 10.1007/s00702-008-0050-7. Epub 2008 May 14.

PMID:
18478178
43.

Botulinum toxins revisited.

Truong DD.

J Neural Transm (Vienna). 2008;115(4):557. doi: 10.1007/s00702-008-0873-2. No abstract available.

PMID:
18404255
44.

Evidence for the effectiveness of botulinum toxin for sialorrhoea.

Truong DD, Bhidayasiri R.

J Neural Transm (Vienna). 2008;115(4):631-5. doi: 10.1007/s00702-007-0861-y. Epub 2008 Feb 4. Review.

PMID:
18250951
45.

Motor complications in Parkinson disease: clinical manifestations and management.

Bhidayasiri R, Truong DD.

J Neurol Sci. 2008 Mar 15;266(1-2):204-15. Epub 2007 Sep 27. Review.

PMID:
17897677
46.

Evidence for effectiveness of botulinum toxin for hyperhidrosis.

Bhidayasiri R, Truong DD.

J Neural Transm (Vienna). 2008;115(4):641-5. Epub 2007 Sep 21. Review.

PMID:
17885725
47.

Ketogenic diet prevents seizure and reduces myoclonic jerks in rats with cardiac arrest-induced cerebral hypoxia.

Tai KK, Truong DD.

Neurosci Lett. 2007 Sep 20;425(1):34-8. Epub 2007 Aug 10.

PMID:
17825488
48.

Management of non-motor symptoms in advanced Parkinson disease.

Truong DD, Bhidayasiri R, Wolters E.

J Neurol Sci. 2008 Mar 15;266(1-2):216-28. Epub 2007 Sep 4. Review.

PMID:
17804018
49.

Post-hypoxic animal model of myoclonus.

Tai KK, Bhidayasiri R, Truong DD.

Parkinsonism Relat Disord. 2007 Oct;13(7):377-81. Epub 2007 Aug 27. Review.

PMID:
17720608
50.

Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus.

Tai KK, Truong DD.

J Neural Transm (Vienna). 2007;114(12):1547-51. Epub 2007 Aug 10.

PMID:
17690949

Supplemental Content

Loading ...
Support Center